Prenetics Global Ltd (PRE): Earnings per share for the last twelve months

Symbol and logo of brand prenetics.com (PRE)

Prenetics Global leads in precision diagnostics by investing in AI-driven DNA analysis and portable tests. The trend of the rolling annual earnings per share illustrates financial resilience, where the -4.17 parameter determines the metric's magnitude. Stable demand for genetics from clinics supports cash flow and operational growth. Efficiency is achieved by outsourcing production and IT infrastructure to external contract partners.

PRE Prenetics Global Earnings per one share for the last 12 months (04/28/2023 - 11/12/2026)

Analytical breakdowns and data insights for company Prenetics Global Limited (PRE)

- stock price and consensus target price:
Stock Price Prenetics Global Ltd|PRE - Analyst Median Target
- stock exchange capitalization data:
Market Value Prenetics Global|PRE - Company Buyout Price
- shareholders' equity book value data:
Net Assets per Single Share Prenetics|PRE - Net Asset Value|Market Value to Book Value Ratio prenetics.com|PRE - Aggregate Asset Value
- issuer credit burden and liquidity indicators:
Total Debt to Capital Prenetics Global|PRE - Long-Term Liabilities to Capital|Short-Term Debt to Equity Prenetics Global Ltd|PRE - Company Aggregate Debt|Debts to Book Capitalization Prenetics Global|PRE - Long-Term Debt|Company Current Liabilities Prenetics|Quick Ratio prenetics.com
- earnings and multiples data:
PRE - Net Financial Result|Projected Future Earnings Prenetics Global|PRE - Price to Earnings Ratio|Future Price to Earnings Prenetics Global Ltd|PRE - Growth-Adjusted Market Cap to Net Income|Enterprise Value to EBITDA Ratio Prenetics Global|PRE - Income before deduction of interest, taxes and amortization|Net earnings per share (EPS TTM) Prenetics|PRE - Net earnings per share for the trailing year|Year-over-year earnings per share growth for the last twelve months prenetics.com|PRE - Earnings per share growth in current year|Net earnings per share growth forecast for next year Prenetics Global
Fundamental valuation:prenetics.com (PRE)
Manufactured products of Prenetics Global Ltd

To identify objective yield benchmarks, investors analyze the annual net income per share, which isolates financial results from the impact of issuance volume. The TTM fundamental net income per share trend confirms the effectiveness of the Prenetics Global (PRE) business model, where high margins from genomic testing and corporate contracts translate into sustainable profit growth and high-quality free cash flow.

Main competitors

Agilent Technologies - Net earnings per share (EPS TTM)|Net earnings per share for the last four quarters questdiagnostics.com DGX|Illumina (ILMN) - Earnings per share for the last twelve months|EXAS - Net earnings per share for the last four quarters|Earnings per share for the last twelve months PerkinElmer|Bio-Rad Corp - Earnings per one share for the last 12 months|Earnings per share for the last twelve months Anbio Biotechnology (NNNN)|SHC (soterahealth.com) - Earnings per share for the trailing year|Net earnings per share (EPS TTM) QDEL (QuidelOrtho Corporation)|OPKO Health Inc (OPK) - Net earnings per one share for the last twelve months|CDNA - Earnings per share for the last twelve months|MRVI (Maravai) - Earnings per share for the last 12 months|FLGT: Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months fluidigm.com (LAB)|Net earnings per share for the last 12 months CTKB|OSUR (OraSure Technologies, Inc.) - Earnings per share for the last four quarters|Net earnings per share (EPS TTM) XGN|Net earnings per share for the last four quarters MDxHealth, Inc.|Net earnings per share (EPS TTM) LUCD (Lucid Diagnostics Inc.)|IMDX - Net earnings per share for the last 12 months|TRIB - Earnings per share for the last twelve months|Net earnings per share for the last four quarters ProPhase Labs Inc PRPH|AIMD (Ainos Corp) - Net earnings per share for the last 12 months|CoDx - Earnings per share for the trailing year|HSCS (Heart Test Laboratories) - Net earnings per share (EPS TTM)|BMRA - Net earnings per share for the trailing year|Earnings per share for the last twelve months Cardio Diagnostics (CDIO)|Earnings per share for the last twelve months ONCO (Onconetix Inc)|Earnings per share for the last twelve months Virax Biolabs Group Ltd VRAX|Bluejay Diagnostics Corp (BJDX) - Net earnings per one share for the last twelve months|Aspira Women's Health - Net earnings per share (EPS TTM)|AXDX: Earnings per share for the last twelve months|CNTG: Net earnings per share (EPS TTM)|Enzo Biochem (ENZ) - Net earnings per share (EPS TTM)|Earnings per share for the last twelve months Fresh2 Group Ltd|Earnings per share for the last twelve months GENE|Earnings per share for the last twelve months 23andMe Holding Co. (ME)|PMD: Earnings per one share for the last 12 months